Company Name of Executive Base Salary ($0) Bonus ($0) Total ($0) Other ($0) Long-Term Comp. ($0) Total Direct Comp. ($0) Potential Realizable Value of Option Grants ($0) FYE Value of Exercisable In-the-Money Options ($0) Aastrom Biosciences Inc.** Todd E. Simpson (1) 166 108 274 0 0 274 479 115 Abgenix Inc. Kurt W. Leutzinger 255 77 332 6 3,007 3,344 1,099 3,981 Adolor Corp. Peter J. Schied 198 38 236 0 0 236 147 1,132 Advanced Tissue Sciences Inc. Nikhil

Definitions & Methodology Using the same 259 proxy statements, we have gathered data on the compensation of Chief Financial Officers (CFOs) in the industry. The sample size of companies shrinks to 183 in the case of CFOs because many companies have no CFO listed among the top wage earners (companies disclose compensation only for the five most highly paid executives or, in the case of small companies, for executives who earn more than $100,000). In addition, a number companies have no CFO

Company Name of Executive Base Salary ($0) Bonus ($0) Total ($0) Other ($0) Long-Term Comp. ($0) Total Direct Comp. ($0) Potential Realizable Value of Option Grants ($0) FYE Value of Exercisable In-the-Money Options ($0) 3-Dimensional Pharmaceuticals Inc. F. Raymond Salemme (1) 283 91 374 5 34 412 277 1,132 Aastrom Biosciences Inc.** Brian S. Hampson 127 44 171 0 0 171 479 9 Abgenix Inc. C. Geoffrey Davis (2) 251 75 327 1 0 328 1,099 4,818 Aclara

Rank Company Name of Executive Base Salary ($0) Bonus ($0) Total ($0) 1 Genentech Inc. Susan D. Desmond-Hellmann (31) 500 425 925 2 Scios Inc. George F. Schreiner 250 645 895 3 MedImmune Inc. James F. Young 429 400 829 4 Gilead Sciences Inc. Norbert W. Bischofberger 375 250 625 5 Genzyme Corp. Alan E. Smith (34) 371 250 621 6 Immunex Corp. Douglas E. Williams (41) 341 266 607 7 Corvas International Inc. George P. Vlasuk 311 265 576 8 Human Genome

For R&D Executives Who Received A Full Year Of Salary, 171 Companies

Definitions & Methodology Using the same 259 proxy statements, we have gathered data on the compensation of executives responsible for Research & Development (R&D) in the industry. The sample size of companies shrinks to 188 in the case of this position because many companies have no such position listed among the top wage earners (companies disclose compensation only for the five most highly paid executives or, in the case of small companies, for executives who earn more than $100,000). In

For Business And Corporate Development Executives Who Received A Full Year Of Salary, 54 Companies

Definitions & Methodology Using the same 259 proxy statements, we have gathered data on the compensation of executives responsible for business and/or corporate development in the industry. The sample size of companies shrinks to 63 in the case of this position because many companies have no such position listed among the top wage earners (companies disclose compensation only for the five most highly paid executives or, in the case of small companies, for executives who earn more than $100,000

Company Name of Executive Base Salary ($0) Bonus ($0) Total ($0) Other ($0) Long-Term Comp. ($0) Total Direct Comp. ($0) Potential Realizable Value of Option Grants ($0) FYE Value of Exercisable In-the-Money Options ($0) 3-Dimensional Pharmaceuticals Inc. Graham R. Brazier 208 80 288 3 0 290 65 0 Aclara Biosciences Inc. Philip A. Petersen 170 40 210 27 0 236 337 1 Albany Molecular Research Inc. Lawrence D. Jones 168 25 193 5 1,416 1,614 303 0 Alliance

Company Name of Executive Base Salary ($0) Bonus ($0) Total ($0) Other ($0) Long-Term Comp. ($0) Total Direct Comp. ($0) Potential Realizable Value of Option Grants ($0) FYE Value of Exercisable In-the-Money Options ($0) Aclara Biosciences Inc. Thomas J. McNaughton 175 34 209 0 0 209 237 1 Advanced Tissue Sciences Inc. Mark J. Gergen (1) 231 43 274 0 0 274 0 0 Affymetrix Inc. Barbara A. Caulfield (2) 155 200 355 0 0 355 4,256 1,363 Alexion Pharmaceuticals

Rank Name of Executive Company Base Salary ($0) Bonus ($0) Total ($0) 1 Peter Wirth (13) Genzyme Corp. 527 309 836 2 William G. Green Chiron Corp. 433 345 778 3 Stephen G. Juelsgaard (11) Genentech Inc. 322 225 547 4 John E. Osborn Cephalon Inc. 268 274 542 5 Mark S. Butler (15) Indevus Pharmaceuticals Inc.*** 265 234 499 6 Barry G. Pea (14) Immunex Corp. 240 258 498 7 John B. Douglas III Millennium Pharmaceuticals Inc. 307 139 446 8 Lee Bendekgey

Definitions & Methodology Using the same 259 proxy statements, we have gathered data on the compensation of executives responsible for legal affairs in the industry. The sample size of companies shrinks to 60 in the case of this position because many companies have no such position listed among the top wage earners (companies disclose compensation only for the five most highly paid executives or, in the case of small companies, for executives who earn more than $100,000). In addition, a number

Rank Name of Executive Company Base Salary ($0) Bonus ($0) Total ($0) 1 M. Nixon Ellis Trimeris Inc. 265 127 392 2 William H. Baum Diversa Corp. 260 130 390 3 John Maraganore Millennium Pharmaceuticals Inc. 266 121 386 4 Ian Edvalson Third Wave Technologies Inc.(a) 233 98 331 5 Martin J. Driscoll Viropharma Inc. 230 99 329 6 Thomas C. Seoh Guilford Pharmaceuticals Inc. 254 74 328 7 Michael T. Dwyer (14) ILEX Oncology Inc. 245 76 321 8 Stephen R

For Legal Officers Who Received A Full Year Of Salary, 53 Companies